Clinical Trial Update: Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins [NA]

View source ↗

Summary

This clinical trial evaluated the immunogenicity of a reduced four-dose rabies vaccine schedule with rabies immunoglobulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies Immunoglobulin (rabies immunoglobulin)
• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Queen Saovabha Memorial Institute | Conditions: Rabies | NA | Status: COMPLETED